爱荷华州癌症登记中口咽癌HPV状态SSF-10变量的准确性
本研究基于爱荷华州癌症登记2010-2014年824例口咽癌患者,按纳入p16检测结果的修改版指南重新编码HPV状态SSF-10变量并与原指南比较。原编码为HPV-16型的187例中89%被重新编码为HPV-NOS。原编码在高等级阳性/阴性/未检测分类中捕获了81%的HPV阳性患者。
要点
- p16是最常用HPV检测,但原指南未纳入p16导致编码不一致。
- 原编码将p16阳性错误等同于HPV-16型。
- 建议增设独立p16变量以提高HPV编码一致性与准确性。
核心结论
- p16检测最常见但未被一致编码为HPV检测,且p16阳性被错误等同于HPV-16型,增设独立p16变量可改善编码一致性。
研究设计与样本
- 基于爱荷华州癌症登记2010-2014年824例口咽癌患者,按纳入p16检测结果的修改版指南重新编码HPV状态并与原指南比较。
主要发现
- 原编码为HPV-16型的187例中89%被重新编码为HPV-NOS。
- 在高等级阳性/阴性/未检测分类中,原编码捕获了81%的HPV阳性癌症患者。
临床怎么用
- 登记编码时应区分p16检测与HPV检测,避免将p16阳性直接归为HPV-16型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Surveillance, Epidemiology, and End Results Cancer Registries (SEER) began collecting human papillomavirus (HPV) status for upper aerodigestive tract cancers in 2010. However, classification of p16-testing was not included in the Collaborative Stage coding guidelines, potentially leading to inconsistent coding. METHODS: The HPV values for Iowa patients with oropharyngeal cancers (n = 824) were recoded based on modified guidelines that included p16 test results, and compared with the original guidelines. RESULTS: Forty percent of patients were recoded to a different value, and the HPV testing rate increased from 45% to 55%; 56% received p16-testing only. Of those originally coded as HPV-type 16 (n = 187), 89% were recoded to HPV-not otherwise specified (NOS). When comparing high-level positive/negative/not done categories, original coding captured 81% of patients with HPV-positive cancers. CONCLUSION: p16 was the most common HPV test but was inconsistently coded as HPV-testing. p16-positivity was also erroneously equated with HPV-type 16. Adding a separate p16 variable would improve consistency and accuracy of HPV coding.
引用
- Kahl AR, Charlton ME, Pagedar NA, et al. Accuracy of the HPV status site-specific factor 10 (SSF-10) variable for patients with oropharyngeal cancers in the Iowa Cancer Registry, 2010-2014. Head Neck. 2018. PMID: 29934978. doi:10.1002/hed.25314
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。